* Bioatla Inc BCAB.OQ reported a quarterly adjusted loss
of 63
cents per share for the quarter ended in December. The mean
expectation of seven analysts for the quarter was for a loss
of 70 cents per share.
* Reported revenue was zero; analysts expected $1.50
million.
* Bioatla Inc's reported EPS for the quarter was a loss
of 63
cents.
* The mean earnings estimate of analysts had risen by
about 1.8%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Bioatla Inc shares had fallen by 72.1% this quarter.
* The company reported a quarterly loss of $27.54 million.
* Wall Street's median 12-month price target for Bioatla Inc
is
$17.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
March 24 at 10:10 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2022 -0.70 -0.63 Beat
Sep. 30 2022 -0.80 -0.69 Beat
Jun. 30 2022 -0.69 -0.77 Missed
Mar. 31 2022 -0.67 -0.65 Beat